|
(b)(4).Information regarding patient age, gender, weight, race, ethnicity, and medical history were not provided.Procode is krd/hcg.(b)(4).Concomitant med products: enpower control cable and detachment control box (dcb2).Initial reporter information such as the name, phone and email address are unknown.[conclusion]: the healthcare professional reported that during the coil embolization procedure to prevent an endoleak at the internal iliac artery, a competitive coil was placed without any issue but the deltafill18 20 mm x 60 cm coil (dlf182060/s11472) failed to detach and was removed; it was reported that the physician was able to complete the procedure was without having to replace the deltafill18 coil.There was no further issue or delay.There was no report of patient injury or complication; the complaint product was new and was stored per labeling instructions.The procedure was conducted in accordance with the instruction for use (ifu) with constant flush maintained at all time.There was no visible defect or damage noted on the product prior to the event.The deltafill18 coil was not available to be returned for product analysis.Based on complaint information, the device was not available to be returned for analysis.A review of manufacturing documentation associated with this lot (s11472) presented no issues during the manufacturing or inspection processes related to the reported complaint.A non-conformance was generated to evaluate the impact of possible contamination observed in a bottle of neutralizer.The neutralizer was determined to be acceptable for use and all product was released.All product rejected during manufacturing was identified as scrap and properly accounted for.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of causes and possible contributing factors could be made.As such the investigation will be closed.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective/preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|